{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Estrogen receptor",
      "Indole",
      "SERD"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33035677",
  "DateCompleted": {
    "Year": "2021",
    "Month": "06",
    "Day": "22"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "06",
    "Day": "22"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2020",
        "Month": "10",
        "Day": "06"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.bmcl.2020.127601",
      "S0960-894X(20)30712-5"
    ],
    "Journal": {
      "ISSN": "1464-3405",
      "JournalIssue": {
        "Volume": "30",
        "Issue": "22",
        "PubDate": {
          "Year": "2020",
          "Month": "Nov",
          "Day": "15"
        }
      },
      "Title": "Bioorganic & medicinal chemistry letters",
      "ISOAbbreviation": "Bioorg Med Chem Lett"
    },
    "ArticleTitle": "Design, syntheses and evaluations of novel indole derivatives as orally selective estrogen receptor degraders (SERD).",
    "Pagination": {
      "StartPage": "127601",
      "MedlinePgn": "127601"
    },
    "Abstract": {
      "AbstractText": [
        "Most estrogen receptor positive (ER +)\u00a0breast cancers depend on ER signaling pathway to develop. Clinical application of SERD fulvestrant effectively degraded ER, blocked its function and prolonged progression free survival of ER\u00a0+\u00a0breast cancer patients. However, current SERD suffers from limited bioavailability, therefore is given as intramuscular (IM) injection. In this paper, we report herein a novel indole series compounds with nanomolar range ER degradation potencies and oral systemic exposures. Selected compounds suppressed tumor growth in vivo in ER\u00a0+\u00a0MCF7 breast cancer CDX model via p.o. administration. All those data supported further optimizations of this analog to develop preclinical candidate as oral SERD for ER\u00a0+\u00a0breast cancer's treatment."
      ],
      "CopyrightInformation": "Copyright \u00a9 2020 Elsevier Ltd. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Luoxin Pharmaceutical (Shanghai) Co., Ltd., Building 1 and 1st-3rd Floors, Building 2, No.85 Faladi Road, China (Shanghai) Pilot Free Trade Zone, Shanghai 201210, China."
          }
        ],
        "LastName": "Dong",
        "ForeName": "Jiaqiang",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Luoxin Pharmaceutical (Shanghai) Co., Ltd., Building 1 and 1st-3rd Floors, Building 2, No.85 Faladi Road, China (Shanghai) Pilot Free Trade Zone, Shanghai 201210, China."
          }
        ],
        "LastName": "Wang",
        "ForeName": "Tie-Lin",
        "Initials": "TL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "WuXi AppTec (Wuhan), 666 Gaoxin Road, East Lake High-tech Development Zone, Wuhan 430075, China. Electronic address: lu_jianyu@wuxiapptec.com."
          }
        ],
        "LastName": "Lu",
        "ForeName": "Jianyu",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "WuXi AppTec (Headquarters), 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China."
          }
        ],
        "LastName": "Ding",
        "ForeName": "Charles Z",
        "Initials": "CZ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "WuXi AppTec (Wuhan), 666 Gaoxin Road, East Lake High-tech Development Zone, Wuhan 430075, China."
          }
        ],
        "LastName": "Hu",
        "ForeName": "Lihong",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "WuXi AppTec (Headquarters), 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China."
          }
        ],
        "LastName": "Hu",
        "ForeName": "Guoping",
        "Initials": "G"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "WuXi AppTec (Wuhan), 666 Gaoxin Road, East Lake High-tech Development Zone, Wuhan 430075, China."
          }
        ],
        "LastName": "He",
        "ForeName": "Huijun",
        "Initials": "H"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "WuXi AppTec (Wuhan), 666 Gaoxin Road, East Lake High-tech Development Zone, Wuhan 430075, China."
          }
        ],
        "LastName": "Zeng",
        "ForeName": "Xu",
        "Initials": "X"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "WuXi AppTec (Wuhan), 666 Gaoxin Road, East Lake High-tech Development Zone, Wuhan 430075, China."
          }
        ],
        "LastName": "Li",
        "ForeName": "Xiaoting",
        "Initials": "X"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "WuXi AppTec (Headquarters), 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China."
          }
        ],
        "LastName": "Sun",
        "ForeName": "Deheng",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "WuXi AppTec (Headquarters), 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China."
          }
        ],
        "LastName": "Zhu",
        "ForeName": "Yingjie",
        "Initials": "Y"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "WuXi AppTec (Headquarters), 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China."
          }
        ],
        "LastName": "Shen",
        "ForeName": "Liang",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "WuXi AppTec (Headquarters), 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China."
          }
        ],
        "LastName": "Gu",
        "ForeName": "Qingyang",
        "Initials": "Q"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "WuXi AppTec (Headquarters), 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China."
          }
        ],
        "LastName": "Chan",
        "ForeName": "Chi-Chung",
        "Initials": "CC"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "WuXi AppTec (Headquarters), 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China."
          }
        ],
        "LastName": "Xia",
        "ForeName": "Yuanfeng",
        "Initials": "Y"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "WuXi AppTec (Headquarters), 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China."
          }
        ],
        "LastName": "Li",
        "ForeName": "Jian",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "WuXi AppTec (Headquarters), 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China."
          }
        ],
        "LastName": "Chen",
        "ForeName": "Shuhui",
        "Initials": "S"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Bioorg Med Chem Lett",
    "NlmUniqueID": "9107377",
    "ISSNLinking": "0960-894X"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antineoplastic Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Indoles"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Receptors, Estrogen"
    },
    {
      "RegistryNumber": "8724FJW4M5",
      "NameOfSubstance": "indole"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Administration, Oral"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "chemical synthesis",
        "pharmacology"
      ],
      "DescriptorName": "Antineoplastic Agents"
    },
    {
      "QualifierName": [
        "drug therapy",
        "metabolism",
        "pathology"
      ],
      "DescriptorName": "Breast Neoplasms"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Cell Proliferation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Dose-Response Relationship, Drug"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Design"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Screening Assays, Antitumor"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "chemical synthesis",
        "pharmacology"
      ],
      "DescriptorName": "Indoles"
    },
    {
      "QualifierName": [],
      "DescriptorName": "MCF-7 Cells"
    },
    {
      "QualifierName": [
        "drug therapy",
        "metabolism",
        "pathology"
      ],
      "DescriptorName": "Mammary Neoplasms, Experimental"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mice"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mice, Inbred BALB C"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Molecular Structure"
    },
    {
      "QualifierName": [
        "antagonists & inhibitors",
        "metabolism"
      ],
      "DescriptorName": "Receptors, Estrogen"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Structure-Activity Relationship"
    }
  ]
}